Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Sanofi-Genzyme
Company Monitoring Page for Sanofi-Genzyme
latest headlines for company on cafepharma
Sanofi Unites Under a Single Purpose at Cambridge Crossing
BioSpace
Mon, 03/14/22 - 10:29 am
Tags:
Sanofi
,
headquarters
,
Cambridge
,
Sanofi Pasteur
,
Sanofi Genzyme
Sanofi Genzyme’s Bill Sibold Champions Diversity, Community Responsibility
BioSpace
Thu, 11/19/20 - 10:38 am
Tags:
Sanofi Genzyme
,
Bill Sibold
,
diversity
Sanofi and Regeneron's medical congress campaign focuses on type 2 inflammation education for docs
Fierce Pharma
Tue, 11/19/19 - 11:36 pm
Tags:
Sanofi Genzyme
,
Regeneron
,
Dupixent
,
inflammation
Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics
Endpoints
Mon, 06/17/19 - 11:26 pm
Tags:
Sanofi Genzyme
,
Voyager Therapeutics
,
gene therapy
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Tags:
Massachusetts
,
Boston
,
Biogen
,
Tecfidera
,
Benepali
,
Shire
,
Takeda
,
Vyvanse
,
Vertex Pharmaceuticals
,
Orkambi
,
Kalydeco
,
Alexion
,
Soliris
,
Strensiq
,
Sanofi Genzyme
,
Lantus
,
Ironwood Pharmaceuticals
,
Linzess
Sanofi Genzyme has its expansive sights set on a new tech campus in Cambridge — report
Endpoints
Mon, 10/15/18 - 10:34 am
Tags:
Sanofi Genzyme
,
headquarters
,
Cambridge MA
Regulus lays off 60% of staff, halts development
Biopharma Dive
Fri, 07/6/18 - 12:18 pm
Tags:
Regulus
,
layoffs
,
restructuring
,
RG-012
,
Sanofi Genzyme
Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years
CP Wire
Tue, 04/24/18 - 09:02 am
Tags:
Sanofi Genzyme
,
Lemtrada
,
MS
,
Relapsing Remitting Multiple Sclerosis
Sanofi Genzyme announces 130 staff cuts
GoinPharma
Thu, 02/8/18 - 11:50 pm
Tags:
Sanofi Genzyme
,
layoffs
,
drug manufacturing
Sanofi Genzyme issues recall for contaminated arthritis gel
Boston Globe, MA
Tue, 12/12/17 - 10:45 pm
Tags:
Sanofi Genzyme
,
recalls
Sanofi Genzyme hit with patent lawsuit over new eczema drug
Bizjournals.com
Thu, 04/20/17 - 09:48 am
Tags:
Sanofi Genzyme
,
patents
,
eczema
,
Dupixent
,
Immunex
,
Amgen
David Meeker, longtime head of Sanofi Genzyme, to leave company after 23 years
Bizjournals.com
Fri, 04/7/17 - 09:46 am
Tags:
David Meeker
,
Sanofi Genzyme
Sanofi Genzyme head weighs in on drug price debate
Bizjournals.com
Fri, 02/3/17 - 11:20 am
Tags:
Sanofi Genzyme
,
drug pricing
Fri, 10/28/16 - 12:09 pm
Tags:
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
Bizjournals.com
Fri, 10/28/16 - 10:19 am
Tags:
FDA
,
Sanofi
,
Sanofi Genzyme
,
drug manufacturing
,
biosimilars
,
Humira
,
Sarilumab
FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
Mon, 09/26/16 - 09:45 am
Tags:
FDA
,
Sanofi Genzyme
,
Regeneron
,
Sarilumab
,
dupilumab
,
eczema
,
rheumatoid arthritis
Sanofi Genzyme Begins Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients with Acid Sphingomyelinase Deficiency
Yahoo
Wed, 07/6/16 - 09:49 am
Tags:
Sanofi Genzyme
,
clinical trials
,
olipudase alfa
,
Niemann-Pick disease
Sanofi Genzyme to begin late-stage trial of new drug for Pompe disease by summer
Bizjournals.com
Fri, 03/4/16 - 02:21 pm
Tags:
Sanofi Genzyme
,
Pompe disease
,
clinical trials
,
NeoGAA
Sanofi Genzyme revenues grow 20% in 2015 to top $4B
Bizjournals.com
Tue, 02/9/16 - 09:06 am
Tags:
Sanofi Genzyme
,
earnings
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.